Central laboratory for pharmacokinetic/pharmacodynamic evaluation of levonorgestrel butanoate for female contraception
Ended Awarded Last action
- Contract number
- 75N94021F00001
- Awardee
-
Oregon Health & Science University UEI NPSNT86JKN51
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $557,412
Award facts
- Opportunity
-
- Contraceptive Development Program NICHD Contraceptive Clinical Trials Network Female Sites Pre-Solicitation · Posted May 7, 2019
- Central Laboratory for Pharmacokinetic/Pharmacodynamic Evaluation of Levonorgestrel Butanoate for Female Contraception Award Notice · Posted Mar 18, 2021
- Contract value 100% obligated
- $557,412.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Portland, OR 97239, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $112,619 | |
| Funding Only Action | $95,077 | |
| Funding Only Action | $199,076 | |
| Funding Only Action | $30,073 | |
| Original award | $120,567 |
About this award
The National Institute of Child Health and Human Development (NICHD) awarded Oregon Health & Science University (OHSU) a delivery order valued at $557,412 on February 9, 2021, to serve as the central laboratory for pharmacokinetic and pharmacodynamic evaluation of levonorgestrel butanoate for female contraception. This work supports NICHD's Contraceptive Development Program and the NICHD Contraceptive Clinical Trials Network for female sites. The contract is structured as a cost-no-fee delivery order, with performance to be conducted in Portland, Oregon, and an ultimate completion date of July 14, 2026. No set-aside designation was applied to this award, indicating competitive selection in the open federal contracting process.
OHSU is well-positioned to perform this specialized laboratory work given its extensive experience as an academic medical center and federal contractor since 2001. The university has established expertise in supporting contraceptive efficacy studies through previous NICHD contract awards and maintains substantial research capabilities across multiple National Institutes of Health funding mechanisms. The institution's comprehensive portfolio of biostatistical support, research core services, and reference laboratory testing aligns directly with the pharmacokinetic and pharmacodynamic evaluation requirements of this contraceptive development initiative.
Quick answers
Who was awarded contract 75N94021F00001?
75N94021F00001 was awarded to Oregon Health & Science University by National Institute of Child Health and Human Development (National Institutes of Health) on February 9, 2021.
How much is contract 75N94021F00001 worth?
The government has obligated $557,412 on 75N94021F00001.
Is contract 75N94021F00001 an order under another contract?
Yes. 75N94021F00001 is a delivery order under 75N94020D00016, an indefinite delivery contract.
Was contract 75N94021F00001 competed?
The extent of competition for 75N94021F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award